207 related articles for article (PubMed ID: 29114736)
21. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
[TBL] [Abstract][Full Text] [Related]
22. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
Roijer A; Eskilsson J; Olsson B
Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
[TBL] [Abstract][Full Text] [Related]
23. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
Nielsen PB; Larsen TB; Skjøth F; Lip GY
JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
[TBL] [Abstract][Full Text] [Related]
24. Are atrial fibrillation patients receiving warfarin in accordance with stroke risk?
Zimetbaum PJ; Thosani A; Yu HT; Xiong Y; Lin J; Kothawala P; Emons M
Am J Med; 2010 May; 123(5):446-53. PubMed ID: 20399322
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.
Vinereanu D; Stevens SR; Alexander JH; Al-Khatib SM; Avezum A; Bahit MC; Granger CB; Lopes RD; Halvorsen S; Hanna M; Husted S; Hylek EM; Mărgulescu AD; Wallentin L; Atar D
Eur Heart J; 2015 Dec; 36(46):3268-75. PubMed ID: 26371113
[TBL] [Abstract][Full Text] [Related]
27. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
[No Abstract] [Full Text] [Related]
29. The Long-Term Use of Warfarin Among Atrial Fibrillation Patients Discharged From an Emergency Department With a Warfarin Prescription.
Atzema CL; Austin PC; Chong AS; Dorian P; Jackevicius CA
Ann Emerg Med; 2015 Oct; 66(4):347-354.e2. PubMed ID: 25964082
[TBL] [Abstract][Full Text] [Related]
30. Underutilization of warfarin for stroke prophylaxis in patients with atrial fibrillation or atrial flutter in Korea.
Lee IH; Kim H; Je NK
J Cardiol; 2015 Dec; 66(6):475-81. PubMed ID: 26242197
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation.
Kjerpeseth LJ; Ellekjær H; Selmer R; Ariansen I; Furu K; Skovlund E
Eur J Clin Pharmacol; 2018 Dec; 74(12):1653-1662. PubMed ID: 30116828
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulant treatment of patients with chronic atrial fibrillation in primary health care in Sweden--a retrospective study of incidence and quality in a registered population.
Nilsson GH; Björholt I; Krakau I
Fam Pract; 2004 Dec; 21(6):612-6. PubMed ID: 15465879
[TBL] [Abstract][Full Text] [Related]
33. Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study.
Turakhia MP; Hoang DD; Xu X; Frayne S; Schmitt S; Yang F; Phibbs CS; Than CT; Wang PJ; Heidenreich PA
Am Heart J; 2013 Jan; 165(1):93-101.e1. PubMed ID: 23237139
[TBL] [Abstract][Full Text] [Related]
34. Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial.
Hong KS; Kwon SU; Lee SH; Lee JS; Kim YJ; Song TJ; Kim YD; Park MS; Kim EG; Cha JK; Sung SM; Yoon BW; Bang OY; Seo WK; Hwang YH; Ahn SH; Kang DW; Kang HG; Yu KH;
JAMA Neurol; 2017 Oct; 74(10):1206-1215. PubMed ID: 28892526
[TBL] [Abstract][Full Text] [Related]
35. Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
Kumar S; de Lusignan S; McGovern A; Correa A; Hriskova M; Gatenby P; Jones S; Goldsmith D; Camm AJ
BMJ; 2018 Feb; 360():k342. PubMed ID: 29444881
[TBL] [Abstract][Full Text] [Related]
36. Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.
McAlister FA; Wiebe N; Hemmelgarn BR
BMJ Open; 2018 Jan; 8(1):e016980. PubMed ID: 29382672
[TBL] [Abstract][Full Text] [Related]
37. Rates of ischemic stroke during warfarin treatment for atrial fibrillation.
Tung JM; Mamdani MM; Juurlink DN; Paterson JM; Kapral MK; Gomes T
Stroke; 2015 Apr; 46(4):1120-2. PubMed ID: 25700291
[TBL] [Abstract][Full Text] [Related]
38. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
[TBL] [Abstract][Full Text] [Related]
39. Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS Trial.
Senoo K; Lip GY
Stroke; 2015 Nov; 46(11):3202-7. PubMed ID: 26463692
[TBL] [Abstract][Full Text] [Related]
40. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
